Eric Mou

University of Iowa — United States

Medicine · Health Sciences

9h-index398citations92works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(48), Lung Cancer Treatments and Mutations(12), Chronic Lymphocytic Leukemia Research(11), Cutaneous lymphoproliferative disorders research(9), CNS Lymphoma Diagnosis and Treatment(9)

Publications92 total

Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study
Blood Advances·2026Open Access
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma
Blood Advances·2025Open Access
Sézary syndrome presenting as vitiligo-like leukoderma with response and repigmentation to mogamulizumab and extracorporeal photopheresis
JAAD Case Reports·2025Open Access
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study
Blood·2025
FLP-R: A clinical prediction model for follicular lymphoma Prognosis in the Relapsed/refractory setting
Blood·2025Open Access
Shorter diagnosis to treatment interval is associated with poor prognosis in patients with peripheral T-cell lymphoma: Analysis from the LEO and MER cohorts
Blood·2025
Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)
Blood·2025Open Access
Prognostic impact of diagnosis-to-treatment interval in follicular lymphoma patients treated with immunochemotherapy: Evidence from an international cohort with independent validation
Blood·2025Open Access
Outcomes in the 2nd decade following follicular lymphoma (FL) diagnosis: Long-term follow-up from the university of Iowa/Mayo Clinic SPORE molecular epidemiology resource (MER)
Blood·2025Open Access
Diagnostic and therapeutic patterns in cutaneous T-cell lymphomas (CTCL): Real-world data from the lymphoma epidemiology outcome-molecular epidemiology resource (LEO-MER) prospective cohort study.
Blood·2025Open Access
External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials
Blood·2025Open Access
Interim analysis of safety and efficacy in a Phase 2 study of MB-105, a CD5.CAR T therapy for patients with relapsed/refractory T cell lymphoma
Blood·2025Open Access
Outcomes of T-cell/histocyte-rich large B-cell lymphoma (THRLBCL): An international LEO/MER and NiHiL collaborative study
Blood·2025Open Access
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study
Leukemia & lymphoma/Leukemia and lymphoma·2025
Patterns of care and outcomes in patients with large B-cell lymphoma not treated with full-dose anthracycline regimens: Outcome analysis from the lymphoma epidemiology of outcomes (LEO) prospective cohort study
Blood·2025Open Access
Predictive performance of the LEO comorbidity index in patients aged 80+ years with large B-cell lymphoma
Blood·2025Open Access
PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course
Blood·2025
Age-stratified prognostic performance of patient- vs disease-related IPI factors in large B-cell lymphoma
Blood·2025
Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts
Blood·2025
Updated efficacy and safety results of the Bruton tyrosine kinase degrader BGB-16673 in patients with relapsed/refractory indolent non-Hodgkin lymphoma from the ongoing phase 1 CaDAnCe-101 study
Blood·2025Open Access
page 1 of 5Next →

Frequent Co-authors

Matthew J. Maurer(20), James R. Cerhan(16), Andrew L. Feldman(11), Thomas M. Habermann(11), Andrew M. Evens(10), Brian K. Link(10), Izidore S. Lossos(9), Christopher R. Flowers(9), Jonathon B. Cohen(8), Brad S. Kahl(8), Stephen M. Ansell(8), Yucai Wang(8), Grzegorz S. Nowakowski(8), Pamela B. Allen(7), Ranjana H. Advani(7), Kerry J. Savage(7), Lorenzo Falchi(7), Jason Hom(7), Lisa Shieh(7), David L. Jaye(7)